Ensurge Micropower ASA - Extraordinary General Meeting held on 3 December 2025
Rhea-AI Summary
Ensurge Micropower (OSE: ENMPY) held an Extraordinary General Meeting on 3 December 2025 as an electronic meeting.
The meeting approved the issuance of 27,433,079 tranche 2 shares from the private placement announced 9 November 2025, a subsequent offering of up to 22,222,222 offer shares to existing shareholders, and the issuance of 67,934,000 warrants to Corning Research & Development Corporation with an exercise price of NOK 1.50. Minutes will be posted on the company website.
Positive
- Tranche 2 shares issued: 27,433,079 approved
- Offer shares reserved: up to 22,222,222 for existing shareholders
- Warrants granted: 67,934,000 to Corning R&D at NOK 1.50
Negative
- Immediate dilution: 27,433,079 new tranche 2 shares
- Further dilution possible: up to 22,222,222 offer shares
- Potential dilution from warrants: 67,934,000 exercisable at NOK 1.50
News Market Reaction – ENMPY
In the trading session that priced this news, ENMPY declined 7.79%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 04 | Prospectus approval | Neutral | -7.8% | Regulator approved prospectus for listing and offering new placement shares. |
| Nov 13 | Capital increase | Neutral | +0.0% | Registered Tranche 1 share capital increase from previously announced private placement. |
| Nov 12 | EGM notice | Neutral | +12.5% | Called EGM to approve Tranche 2, subsequent offering, warrants and authorizations. |
| Nov 10 | Ex-date notice | Neutral | +0.0% | Announced ex-date for potential repair issue/subsequent offering without final terms. |
| Nov 10 | Ex-date notice NO | Neutral | +0.0% | Norwegian-language notice of ex-date tied to potential repair issue. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has centered on equity issuance, repair issues, and regulatory steps around a large private placement, with mixed price reactions and several neutral corporate actions producing both aligned and divergent moves.
Over the last month, Ensurge’s disclosures have focused on financing and corporate actions. In November 2025, it announced and registered a private placement totaling 111,111,111 new shares for NOK 100 million, plus an ex-date for a possible repair issue. A notice on 3 December 2025’s EGM outlined Tranche 2, a subsequent offering, and Corning-related warrants. The 4 December 2025 prospectus approval further advanced listing and offering processes. Today’s EGM outcome confirms and implements these previously signaled steps.
Key Terms
private placement financial
subsequent offering financial
warrants financial
exercise price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Oslo, 3 December 2025
An Extraordinary General Meeting in Ensurge Micropower ASA (the "Company") was held today as an electronic meeting. All items on the agenda were adopted in accordance with the proposals of the Board of Directors in the notice to the Extraordinary General Meeting, including, among other things, the issuance of 27,433,079 tranche 2 shares in the private placement announced on 9 November 2025, a subsequent offering of up to 22,222,222 offer shares to existing shareholders not participating in such private placement (more details to follow in a separate stock exchange announcement), and the issuance of 67,934,000 warrants to Corning Research & Development Corporation, each warrant with an exercise price of NOK 1.50.
The minutes from the Extraordinary General Meeting will be made available on the Company's website.
About Ensurge Micropower:
Ensurge (www.ensurge.com) powers the future of AI-enabled devices with advanced microbattery technology that delivers unmatched performance and safety. From its base in San Jose, California, the Company's team of battery specialists have pioneered thin-film batteries produced on high-precision roll-to-roll production processes. These innovations enable new possibilities in form-factor-constrained applications across consumer, medical, and industrial markets. Ensurge partners with leading global customers to accelerate their products to market and is listed on the Oslo Stock Exchange. For more news and information on Ensurge, please visit https://www.ensurge.com/news-room.
For more information, please contact:
Shauna McIntyre - Chief Executive Officer E- mail: shauna.mcintyre@ensurge.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.